Is Affine Formulations a good quality company?

Data is not available for this company.

What is Affine Formulations share price return in the past 10 years?

Data is not available for this company

Affine Formulations Ltd - Stock Valuation and Financial Performance

Name: Affine Formulations
Brand: Affine Formulations

BSE: 0 | NSE: | Pharmaceuticals & Drugs | Small Cap

Place order

BSE Share Price
Not Listed

DeciZen - make an informed investing decision on Affine Formulations

Based on:

Data

DeciZen not available for IPO

10 Year X-Ray of Affine Formulations:

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Standalone Basis ^P Consolidated Basis

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Value Creation ⓘ

Value Creation Index Colour Code Guide ⓘ

	Mar'13	Mar'14	Mar'15	Mar'16	Mar'17	TTM
ROCE % ⓘ	10.1%	9.5%	7.3%	10.5%	9.6%	-
Growth Parameters ⓘ Growth Parameters Colour Code Guide ⓘ
Sales ⓘ	21.6	31.3	32.4	24.3	25.1	25
Sales YoY Gr.	-	45.4%	3.5%	-25.1%	3.5%	-
Adj EPS ⓘ	1.3	1.2	0.6	1.8	1.6	1.6
YoY Gr.	-	-12.2%	-46.1%	187.1%	-8.4%	-
BVPS (₹) ⓘ	10.3	11.3	11.9	13.7	15.3	15.3
Adj Net Profit ⓘ	0.7	0.7	0.4	1.1	1	1
Cash Flow from Ops. ⓘ	0.5	0.5	0.9	2.1	0.1	-
Debt/CF from Ops. ⓘ	18.9	19.9	11.5	4.5	120	-

CAGR ⓘ

CAGR Colour Code Guide ⓘ

	9 Years	5 Years	3 Years	1 Years
Sales ⓘ	NA	NA	-7.1%	3.5%
Adj EPS ⓘ	NA	NA	12.3%	-8.4%
BVPSⓘ	NA	NA	10.7%	11.8%
Share Price	-	-	-	-

Key Financial Parameters ⓘ

Performance Ratio Colour Code Guide ⓘ

	Mar'13	Mar'14	Mar'15	Mar'16	Mar'17	TTM
Return on Equity % ⓘ	12.8	11	5.4	13.9	11.2	10.7
Op. Profit Mgn % ⓘ	10.7	6.9	6.8	12.2	11.5	NAN
Net Profit Mgn % ⓘ	3.4	2.2	1.2	4.4	3.9	3.9
Debt to Equity ⓘ	1.7	1.5	1.4	1.1	1.1	-
Working Cap Days ⓘ	0	182	194	267	286	0
Cash Conv. Cycle ⓘ	0	119	126	170	188	0

Recent Performance Summary

Recent Performance Summary not available for IPO

Latest Financials - Affine Formulations Ltd.

	Standalone	Consolidated
TTM EPS (₹)	1.6	-
TTM Sales (₹ Cr.)	25.1	-
BVPS (₹.) ⓘ	15.3	-
Reserves (₹ Cr.) ⓘ	3	-
P/BV ⓘ	0.00	-
PE ⓘ	0.00	-

From the Market
52 Week Low / High (₹)	0.00 / 0.00
All Time Low / High (₹)	- / -
Market Cap (₹ Cr.)	0
Equity (₹ Cr.)	6
Face Value (₹)	10
Industry PE ⓘ	47.6

Management X-Ray of Affine Formulations:

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged ^*

0.00

* Pledged shares as % of Promoter's holding (%)

Valuation of Affine Formulations

Analyst's Notes

This is a premium feature, Please click here to check our solutions.

Key Ratios of Affine Formulations

Standalone Basis Consolidated Basis

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)

Standalone Basis Consolidated Basis

PARTICULARS	Mar'13	Mar'14	Mar'15	Mar'16	Mar'17
Sales	21.55	31.33	32.43	24.29	25.14
Operating Expenses ⓘ	19.25	29.15	30.23	21.34	22.26
Manufacturing Costs	0.36	0.39	0.43	0.24	0.25
Material Costs	18.13	27.85	28.80	20.18	20.77
Employee Cost	0.59	0.68	0.76	0.69	0.82
Other Costs ⓘ	0.17	0.24	0.24	0.22	0.42
Operating Profit ⓘ	2.30	2.17	2.20	2.96	2.88
Operating Profit Margin (%)	10.7%	6.9%	6.8%	12.2%	11.5%
Other Income ⓘ	0.02	0.06	0.05	0.04	0.11
Interest ⓘ	1.21	1.21	1.21	1.05	1.12
Depreciation ⓘ	0.30	0.27	0.58	0.58	0.57
Exceptional Items ⓘ	0	0	0	0	0
Profit Before Tax ⓘ	0.81	0.75	0.46	1.38	1.30
Tax ⓘ	0.07	0.06	0.09	0.31	0.33
Profit After Tax	0.74	0.69	0.37	1.07	0.98
PAT Margin (%)	3.4%	2.2%	1.2%	4.4%	3.9%
Adjusted EPS (₹)	1.3	1.2	0.6	1.8	1.6
Dividend Payout Ratio (%)	0%	0%	0%	0%	0%

Balance Sheet

(All Figures are in Crores.)

Standalone Basis Consolidated Basis

PARTICULARS	Mar'13	Mar'14	Mar'15	Mar'16	Mar'17
Equity and Liabilities
Shareholders Fund	5.79	6.77	7.14	8.21	9.19
Share Capital ⓘ	0.94	1	1	1	6
Reserves ⓘ	4.85	5.77	6.14	7.21	3.19
Minority Interest	0	0	0	0	0
Debt	9.06	9.67	9.75	9.12	9.97
Long Term Debt	4.60	5.27	4.64	4.61	5.42
Short Term Debt	4.46	4.40	5.12	4.51	4.55
Trade Payables	4.28	5.35	5.27	5.10	6.44
Others Liabilities ⓘ	1.63	1.05	1.01	0.73	0.63
Total Liabilities ⓘ	20.75	22.84	23.17	23.16	26.23
Fixed Assets
Gross Block	7.24	7.28	7.28	7.35	7.54
Accumulated Depreciation	1.37	1.64	2.22	2.80	3.36
Net Fixed Assetsⓘ	5.87	5.64	5.07	4.56	4.17
CWIP ⓘ	0	0	0	0	0
Investmentsⓘ	0	0	0	0	0
Inventories	6.35	8.46	8.73	9.46	8.16
Trade Receivables	7.72	7.75	8.64	8.08	13.18
Cash Equivalents	0.36	0.54	0.36	0.79	0.43
Others Assetsⓘ	0.45	0.45	0.37	0.27	0.28
Total Assets ⓘ	20.75	22.84	23.17	23.16	26.23

Cash Flow

(All Figures are in Crores.)

Standalone Basis Consolidated Basis

PARTICULARS	Mar'13	Mar'14	Mar'15	Mar'16	Mar'17
Cash Flow From Operating Activity ⓘ	0.53	0.49	0.87	2.05	0.08
PBT ⓘ	0.81	0.75	0.46	1.38	1.30
Adjustment ⓘ	1.50	1.46	1.77	1.61	1.67
Changes in Working Capital ⓘ	-1.78	-1.71	-1.22	-0.55	-2.47
Tax Paid ⓘ	0	-0.01	-0.15	-0.38	-0.41
Cash Flow From Investing Activity ⓘ	-0.07	-0.01	0.08	0.06	-0.17
Capex	-0.01	-0.04	-0.01	-0.07	-0.18
Net Investments	0	0	0	0	0
Others ⓘ	-0.07	0.03	0.09	0.12	0.01
Cash Flow From Financing Activityⓘ	-0.33	-0.31	-1.13	-1.68	-0.27
Net Proceeds from Shares ⓘ	0	0.30	0	0	0
Net Proceeds from Borrowing ⓘ	-1.23	0.67	-0.63	-0.03	0.81
Interest Paid ⓘ	-1.21	-1.21	-1.21	-1.05	-1.12
Dividend Paid ⓘ	0	0	0	0	0
Others ⓘ	2.12	-0.06	0.71	-0.60	0.04
Net Cash Flow ⓘ	0.12	0.18	-0.17	0.43	-0.36

Finance Ratio

Standalone Basis Consolidated Basis

PARTICULARS	Mar'13	Mar'14	Mar'15	Mar'16	Mar'17
Ratios
ROE (%)	12.78	10.96	5.38	13.94	11.21
ROCE (%)	12.86	12.13	9.96	14.08	13.29
Asset Turnover Ratio	1.04	1.44	1.41	1.05	1.02
PAT to CFO Conversion(x)	0.72	0.71	2.35	1.92	0.08
Working Capital Days
Receivable Days	131	90	92	126	154
Inventory Days	108	86	97	137	128
Payable Days	86	63	67	94	101

Affine Formulations Ltd Stock News

Affine Formulations Ltd FAQs

What is the share price of Affine Formulations?

Company share prices are keep on changing according to the market conditions. The closing price of Affine Formulations on 01-Jan-1970 05:30 is ₹0.00.

What is the market cap of Affine Formulations?

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 01-Jan-1970 05:30 the market cap of Affine Formulations stood at ₹0.00.